Syllable vs Fini

Syllable vs Fini

Syllable and Fini both sell AI agents for healthcare conversations, and both are unusually transparent about price, but the two rate cards are built very differently.

Syllable and Fini both sell AI agents for healthcare conversations, and both are unusually transparent about price, but the two rate cards are built very differently.

Date

Date

Reading time

Reading time

12 min read

12 min read

About image

One flat rate vs. a metered rate card

A health system pricing out AI agents for its patient-access line usually hits the same wall: most vendors won't say a number out loud. Syllable is a genuine exception, it publishes real metered rates. Fini is also an exception, but a different kind, one flat number per resolution instead of a line-item rate card.

In this comparison: What each is · How they differ · Capabilities · Feature by feature · Ease of use · What customers say · The full side-by-side · Which to choose · Compliance · FAQ

What is Fini?

Fini is an AI customer-support agent priced per resolution, backed by Y Combinator and Matrix Partners. It connects natively to your helpdesk, knowledge base, CRM, billing, claims, and EHR systems, reaches a 90% resolution rate at 99% accuracy, and is built to be live in 14 days and fully autonomous in 30. Across its customer base, Fini handles more than 3 million monthly resolutions in fintech and healthcare. The agent works across voice, chat, and email, answers in 130+ languages, and returns a first response in about five seconds.

Pricing starts at $0.49 per resolution, with no per-seat fees, so a team can model its own cost from ticket volume alone, before a sales conversation ever starts.

Fini resolution rate, accuracy, first response time, and go-live stats

What is Syllable?

Syllable is a Mountain View-based AI agent company, reportedly founded in 2016 by CEO Kobus Jooste, a former Google Director of Software Engineering who worked on Google Assistant and Search. Syllable has raised between $85.6 million and $103 million depending on the data provider, with confirmed rounds including a $28 million Series B in June 2021 led by Oak HC/FT and a $40 million Series C in April 2022 led by TCV. It is not Y Combinator or Matrix Partners backed.

Syllable's anchor product, the Patient Assistant, handles scheduling, routing, refills, and triage over phone, web, and SMS for health systems. In 2024 the company acquired Actium Health, a healthcare patient-engagement company, and has since repositioned around a broader "Agentic Platform" for building and running AI agents across healthcare, insurance claims, and other verticals, while healthcare remains its primary go-to-market focus. Named customers include MemorialCare, Houston Methodist, and Virtua Health.

Syllable pricing in 2026

Syllable publishes real metered rates, a genuine departure from the typical enterprise healthcare AI playbook: SIP connection and recording fees measured in fractions of a cent per 60 seconds, enterprise voice at $0.06 per 60 seconds, text processing priced per million characters, and tool calls priced per million tokens, with third-party model costs passed through separately. Large, custom health-system contracts still route through direct sales rather than the published rate card.

Fini publishes a single number instead: $0.49 per resolution, starting rate, with no per-seat fees and no separate line items for voice minutes, text characters, or tokens. A Syllable buyer can see real prices, but has to add up several metered components to estimate a monthly bill. A Fini buyer multiplies one number by expected ticket volume.

What buyers ask

Syllable

Fini

Published price list

✓, metered rate card

✓, flat rate

Price

Multiple line items, e.g. $0.06 per 60s voice

$0.49 per resolution

Rate for additional usage

Same metered rate, auto-recharge above a threshold

N/A, flat rate

Large enterprise contracts

Custom, quoted per health system

Same published rate at any volume

Can you model cost from one number?

No, requires summing several metered lines

Yes

See Fini's full pricing breakdown for plan details, add-ons, and a resolution calculator.

Fini per-resolution pricing starting from $0.49, no per-agent charges

How Fini and Syllable differ

Both companies publish real prices, a genuine rarity in this category, but the shape of that pricing differs sharply. Syllable's metered rate card covers SIP connections, voice minutes, text characters, and token usage as separate line items, plus a pass-through charge for whatever underlying model a deployment uses, while large health-system contracts are still quoted individually. Fini collapses all of that into one number, a starting rate of $0.49 per resolution, so a support leader can size next month's cost from ticket volume alone rather than modeling voice minutes against text characters against token usage separately.

The two companies also differ in vertical scope and history. Syllable started as a healthcare-only voice bot and has since repositioned as a horizontal, model-neutral Agentic Platform spanning healthcare, insurance claims, and other verticals, folding in Actium Health's patient-engagement technology along the way. Fini has held a consistent fintech-and-healthcare focus throughout, with native connections into claims and EHR systems built specifically for those two regulated industries.

Capabilities side by side

Both platforms genuinely execute tasks rather than only answering questions. Syllable's Patient Assistant handles scheduling, routing, prescription refills, and triage over phone, web, and SMS, and its broader Agentic Platform adds a no-code "Meta Agent Builder," multi-cloud deployment across AWS, GCP, Azure, and OCI, and distributed tracing for conversation analytics. Fini connects natively across helpdesk, CRM, billing, claims, and EHR systems in one connector set, and adds voice as a native channel alongside chat and email.

Syllable markets itself as model-neutral, letting a customer choose and switch underlying LLMs, and states 99.99% platform uptime with 5 million-plus calls automated annually across its customer base. Fini publishes its outcome metrics directly instead: a 90% resolution rate at 99% accuracy, covered further in the Compliance section below.

Fini's per-resolution rate is one number; Syllable's rate card has separate lines for voice, text, and tokens

Feature by feature

Feature

Fini

Syllable

Channels

Voice, chat, email

Voice, web chat, SMS

Model choice

Not published as a buyer-facing choice

✓, model-neutral, switch anytime

Fintech workflows (billing, claims)

✓, native

Insurance claims listed as a target vertical, no named payer customer found

Self-serve signup

Not self-serve, staged onboarding team instead

✓, metered self-serve account with free trial minutes

Published outcome guarantee

✓ (90-Day Money-Back Guarantee)

None published

Ease of use and admin experience

Syllable's own case studies cite some of the fastest deployment timelines in this category: Virtua Health went live with scheduling workflows in 3 weeks, and MemorialCare replaced its entire navigation-center phone tree in under 8 weeks. There is no published, company-wide implementation SLA beyond these specific case studies, though. Fini's published staged rollout (live in 14 days, fully autonomous in 30) is run by a dedicated onboarding team against a fixed timeline that applies to every customer, not just the fastest examples.

A verified G2 or Capterra rating could not be independently confirmed for Syllable at the time of this research; its G2 listing exists under the product name "Syllable Patient Assistant" but the review page could not be accessed, and no Capterra listing was found. Buyers should check G2 directly for current rating data.

Fini's differentiators

One number instead of a rate card

$0.49 per resolution, starting rate, versus summing SIP, voice, text, and token line items to estimate a bill.

Fintech and healthcare, not a broad horizontal spread

Native connections into claims and EHR systems built for two regulated industries specifically.

A fixed, staged rollout for every customer: live in 14 days, fully autonomous in 30

Not just the fastest case studies, a published timeline that applies company-wide.

A published outcome guarantee

The 90-Day Money-Back Guarantee ties payment to a 90% resolution rate within 90 days, at a publicly quoted rate.

90 percent of tickets resolved autonomously by Fini, 10 percent escalated to humans

Syllable's recognized strengths

Syllable earns real credit on specific, well-sourced points. Publishing a real, metered rate card is a genuinely unusual move in enterprise healthcare AI, where most competitors hide pricing entirely behind a sales call, and it lets a technical buyer estimate cost without a demo first. Its founding team includes a former Google Director of Software Engineering who worked on Google Assistant, a credible technical pedigree. And its investor bench includes healthcare strategics like CVS Health, BlueCross BlueShield Venture Partners, and MemorialCare Innovation Fund, several of which also appear to be customers, a pattern that suggests real, invested confidence in the product from inside the industry it serves.

What customers say

A verified G2 or Capterra rating could not be independently confirmed for Syllable at the time of this research. Its own published case studies report that MemorialCare now handles 100% of patient navigation center calls with AI agents, deployed in under eight weeks, and Houston Methodist reduced average handle time by more than 50% on a scheduling automation, a figure also published on Houston Methodist's own site rather than Syllable's marketing alone. These are largely self-reported figures, with the Houston Methodist number carrying slightly stronger corroboration since the customer itself publishes it.

Fini customer testimonial from Crystal Stephens, Head of Operations at Atlas

The full side-by-side


Fini

Syllable

Pricing

$0.49 per resolution, starting rate

Metered rate card across several line items

Outcome guarantee

90-Day Money-Back Guarantee, 90% in 90 days

None published

Go-live

Live in 14 days, fully autonomous in 30, every customer

3 to 8 weeks in cited case studies, no general SLA

Channels

Voice, chat, email

Voice, web chat, SMS

Vertical scope

Fintech and healthcare

Healthcare-anchored, expanding to a horizontal platform

Compliance

SOC 2 Type II, ISO 27001, GDPR, HIPAA-BAA-eligible, CCPA under agreement

SOC 2 Type II, HITRUST e1, HIPAA/BAA reported by third parties, not confirmed on Syllable's own site

Backing

Y Combinator, Matrix Partners

$85.6M-$103M raised (Oak HC/FT, TCV, Section 32)

Named customers

3M+ monthly resolutions across fintech and healthcare

MemorialCare, Houston Methodist, Virtua Health

Which should you choose?

Choose Fini if you want one flat, published per-resolution rate you can model from ticket volume alone, a fixed rollout (live in 14 days, fully autonomous in 30) for every customer, and coverage across both fintech and healthcare workflows including claims and EHR systems. Choose Syllable if you want model-neutral flexibility to switch underlying LLMs and are comfortable estimating cost across several metered line items rather than one flat rate.

A useful gut check: if your team needs fintech workflows alongside healthcare ones, or wants a single number to budget against before any usage begins, Fini's flat rate and rollout (live in 14 days, fully autonomous in 30) are built for exactly that situation. If you specifically want to choose and switch the underlying AI model yourself and are fine reconciling a multi-line metered bill, Syllable's platform is the more relevant comparison. See how Fini also compares against Ushur and Hyro, two other healthcare-focused platforms in this category.

Compliance

Fini publishes SOC 2 Type II, ISO 27001, GDPR compliance, HIPAA-compliant BAA-eligible contracting, and CCPA availability under agreement, all listed together in one place. Third-party healthcare-AI vendor roundups report that Syllable holds SOC 2 Type II certification, HITRUST e1 certification, and HIPAA compliance with a signed BAA, along with SSO, MFA, and role-based access controls, but these claims could not be confirmed directly on Syllable's own site, whose dedicated security or trust page returned a 404 during this research. No ISO 27001 certification was found for Syllable in any source.

That sourcing gap is worth raising directly with Syllable's sales team before signing, since third-party reporting is a weaker form of evidence than a vendor's own published trust center. A team with a hard ISO 27001 requirement has no confirmed claim to evaluate from Syllable at all.

Ready to compare on your own data?

The fastest way to know which platform actually fits your ticket volume and compliance requirements is to run the numbers against your own data rather than a vendor's published averages. See Fini's plans or talk to the team about a side-by-side pilot. If you're also weighing another healthcare-focused platform, our Hyro vs Fini comparison covers a similarly healthcare-anchored alternative, and our explainer on KYC automation covers how onboarding-checks workflows work across this category.

Frequently Asked Questions

Is Syllable's pricing public?

Yes, unusually for enterprise healthcare AI. Syllable publishes a metered rate card covering SIP, voice, text, and token usage as separate line items, though large custom health-system contracts still go through direct sales. Fini publishes a single flat rate instead: $0.49 per resolution.

Who founded Syllable and when?

Syllable was reportedly founded in 2016 by CEO Kobus Jooste, a former Google Director of Software Engineering who worked on Google Assistant. The company is headquartered in Mountain View, California (some directories list Sunnyvale).

How much has Syllable raised?

Reported figures range from $85.6 million to $103 million depending on the data provider, with confirmed rounds including a $28 million Series B in June 2021 led by Oak HC/FT and a $40 million Series C in April 2022 led by TCV. It is not Y Combinator or Matrix Partners backed.

Is Syllable still healthcare-only?

No. Syllable started as a healthcare-only voice bot but has repositioned around a broader "Agentic Platform" spanning healthcare, insurance claims, and other verticals, while healthcare remains its primary go-to-market focus. Fini covers fintech and healthcare specifically, with native claims and EHR connections.

How fast can each platform go live?

Fini publishes a staged rollout for every customer: live in 14 days, fully autonomous in 30. Syllable's case studies cite 3 to 8 week deployments for specific customers, but there is no general company-wide implementation SLA published.

What did Syllable's Actium Health acquisition add?

Syllable acquired Actium Health, a healthcare patient-engagement company, in March 2024, expanding its capabilities beyond its original Patient Assistant scheduling and triage product.

Is Syllable SOC 2 and HIPAA compliant?

Third-party healthcare-AI vendor roundups report that Syllable holds SOC 2 Type II and HITRUST e1 certification and HIPAA compliance with a signed BAA, but these claims could not be confirmed directly on Syllable's own site during this research. Fini publishes SOC 2 Type II, ISO 27001, GDPR, HIPAA-BAA-eligible contracting, and CCPA together on its own site.

Does Fini offer any guarantee Syllable doesn't?

Fini's 90-Day Money-Back Guarantee ties payment to results, a 90% resolution rate within 90 days, at a publicly quoted rate. No equivalent outcome guarantee was found published on Syllable's site.

Who are Syllable's named customers?

MemorialCare, Houston Methodist, and Virtua Health are named customers with published case studies on Syllable's own site, alongside NewYork-Presbyterian, named in secondary coverage without a published metric.

Does Syllable have independent reviews on G2 or Capterra?

A verified G2 or Capterra rating could not be independently confirmed for Syllable at the time of this research. Its G2 listing exists under the product name "Syllable Patient Assistant," but the review page could not be accessed, and no Capterra listing was found.

>